Skip to main content
Premium Trial:

Request an Annual Quote

CollabRx Inks Distribution Partnership with Projects In Knowledge

Premium

CollabRx said this week that is has signed a multi-year agreement with Projects In Knowledge, a developer of digital and mobile information tools and continuing medical education programs, to jointly distribute software applications to over 35,000 oncologists and clinicians in its clinician network.

Under the terms of the agreement, the partners will integrate CollabRx's Therapy Finder applications into Projects In Knowledge's @Point of Care360 platform, an interactive medical textbook that gives clinicians access to educational resources.

CollabRx's Therapy Finder is a series of web-based applications for oncology that help clinicians and their patients select the most appropriate treatments for tumors. These apps use data from an underlying proprietary knowledgebase that the company has developed that contains aggregated data from multiple public sources including published papers, conference abstracts, clinical trials, and diagnostic guidelines (BI 2/22/2013).

The partners said that they will seek support from pharmaceutical and biotechnology companies in the form of educational grants to conduct their initial activities and that they will explore other fundraising mechanisms to support later phases of the partnership.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.